Dermatology Nurses Association 26th Annual Convention
Expert Commentary by: Jennifer Clay Cather, MD
Overview:
Psoriasis is a chronic, immune-mediated disease characterized by recurring and remitting inflammatory disease, ranging from mild to severe and affecting the skin, the scalp, and sometimes the joints. Psoriasis affects approximately 2% of the general population, with a peak onset in young adulthood. Psoriasis has a detrimental impact on quality of life and may lead to emotional suffering and frustration. Moreover, approximately 20% to 25% of patients with psoriasis have extensive disease requiring systemic therapy.
Author: Joel L. Cohen, MD, Director, AboutSkin Dermatology and DermSurgery, Englewood and Lone Tree, Colorado
Introduction
While the
current FDA approval for topical photodynamic therapy (PDT) remains the
treatment of actinic keratoses, the spectrum of clinical conditions that have
reports of efficacy with PDT continues to grow. [more ...]
